Invokana Amputation Settlement Lawsuit. In order to qualify for an Invokana or Invokamet amputation lawsuit settlement, a patient must have taken Invokana or Invokamet and developed serious amputation side effects involving toes, feet or leg amputations.
Johnson & Johnson the world’s largest pharmaceutical and medical device maker and its Janssen subsidiary are under the hammer over serious allegations that the companies failed to warn about severe side effects from its blockbuster line of new diabetic medications.
The allegations at the heart of many similar product liability and personal injury lawsuits are that the companies failed to provide adequate warnings about the potential side effects of Invokana and Invokamet.
What is Invokana?
Invokana also known as canagliflozin was approved in 2013, as the first member of a new class of diabetes drugs, known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.
SGLT2 inhibitors act in a unique way by excreting or releasing more glucose or sugar into the urine. Other SGLT2 inhibitors include Invokamet, Jardiance, Farxiga, and Xigduo to name a few.
Over the last few years, many diabetic patients have switched to Invokana, from other diabetic medications such as Avandia (linked to cardiovascular side effects) and Actos (linked to bladder cancer).
Now severe Invokana side effects have been discovered including Invokana amputation risks, diabetic ketoacidosis, kidney failure, heart attacks and other catastrophic injuries.
FDA Warns about Invokana Amputation Risk
Based on new data from two large clinical trials, the FDA in May 2017 concluded that the type 2 diabetes medicines Invokana, Invokamet, Invokamet XR caused an increased risk of leg and foot amputations.
The FDA is requiring new warnings, including their most prominent Boxed Warning, to be added to the Invokana drug labels to describe this risk.
As patients become aware of the amputee side effects, injured patients are filing product liability lawsuits that claim that Invokana directly caused the amputation of their leg, foot or toes.
FDA Invokana Diabetic Ketoacidosis Warnings
In December 2015, the FDA required Johnson & Johnson to add new diabetic ketoacidosis warnings to Invokana, highlighting that the medication significantly increases the risk of this potentially deadly condition.
Patients were advised by the FDA to stop taking Invokana and seek medical attention immediately if they have any symptoms of ketoacidosis, a condition when the body produces high levels of blood acids called ketones.
In June 2016, the FDA required additional label warnings about the link between Invokana and kidney risks, highlighting that the medication may increase the risk of acute kidney injury.
Invokana Amputation Settlement Lawsuit
Since December 2016, all federally-filed Invokana Diabetes Amputee Lawsuits have been consolidated as part of the federal Invokana multidistrict litigation (MDL), which is centralized before U.S. District Judge Brian Martinotti in the District of New Jersey to coordinate discovery and pretrial proceedings.
If you or someone you know succumbed to an Invokana Ketoacidosis, leg, foot, toes amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes, please call us for further information at 888-210-9693. Dr. Shezad Malik Law Firm is investigating Invokana Ketoacidosis, leg amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes.
Read more about Invokana side effects here